Vivere Oncotherapies
Berkeley
About Vivere Oncotherapies
Vivere develops targeted cancer therapies that activate the immune system to detect and destroy tumors using engineered bio-platforms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $10.0M
- Funding stage: Seed
- Last round: Grant (Jan 2026)
- Website: viveretx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/vivere-oncotherapies-92735 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.